Article
Mesenchymal stem cells alleviate autoimmune thyroiditis by modulating macrophage phenotypes and through influencing the STING pathway.
Tissue & cell - 1 Dec 2024
Ding Haoran, Qin Jiabo, Liu Zhijian, Shi Xianbiao, Guan Wenxian, Sang Jianfeng
Abstract excerpt
BACKGROUND: Hashimoto's thyroiditis is a chronic autoimmune inflammatory disease with a high prevalence and currently lacks effective treatment options. Previous preclinical and clinical trials have established mesenchymal stem cells (MSCs) as a promising therapeutic approach; however, there is limited research on MSC treatment for Hashimoto's thyroiditis, and the underlying molecular mechanisms remain unclear....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
